维普中文期刊产品整合服务
44篇 您的检索式:作者名="Colonno R"
    题名 作者 年代 出处 被引量
1Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir显示文摘Ying C Colonno R Clercq ED 2007Antiviral Res2007,73,3:1
2Long-term entecavir treatment results in sustainedan tiviral eficacy and prolonged life span in the wood-chuck model of chronic hepatitis infection 显示文摘Colonno R J Genovesi EV Medina I 2001Infect Dis2001,184,10:1
3Emergence ofentecavir resistant hepatitis B virus after one year of therapy in phase Ⅱ&Ⅲ studies is only observed in lamivudine refractory patients显示文摘Colonno RJ Rose R Levine SM 2004Hepatology2004,4041,:1
4In vitro inhibition of hepadnavirus polymerasas by the triphosphates of BMS_200475 and lobueavir显示文摘Seifer M Hamatake RK Colonno R J 1998Antimierob Agents Chemother1998,42,12:1
5Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection显示文摘Colonno R J Genovesi EV Medina I 2001J Infect Dis2001,184,10:1
6In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir显示文摘SEIFER M HAMATAKE R K COLONNO R J 1998Antimicrob Agents Chemother1998,42,12:1
7Entecavir two year resistance update: no resistance observed in nucleoside naive patients and low frequency resistance emergence in lamivudine refractory patients 显示文摘Colonno RR Rose R Levine S 2005Hepatology2005,42,1:1
8Entecavir resistance is rare in nucleoside naive patients with hepatitis B 显示文摘Colonno R J Rose R Baldick C J 2006Hepatology2006,44,6:1
9Entecavir resistance is rare in nucleoside naive patients with hepatitis B显示文摘COLONNO RJ ROSE R BALDICK CJ 2006Hepatology2006,44,6:1
10In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and fobucavir 显示文摘Seifer M Hamatake PK Colonno R J 1998Antimicrob Agents Chemother1998,42,12:1
11Assessment at three years shows high barrier to resistance is maintained in entecavir- treated nucleoside naive patients while resistance emergence in- creases over time in lamivudine refractory patient 显示文摘Colonno R J Rose RE Pokomowski K 2006Hepatology2006,44,1:1
12Emergence of entecavir resistant hepatitis B virus after one year of therapy in phase Ⅱ & III studies is only observed in lamivudine refractory patients显示文摘Colonno R J Rose R Levine SM 2004Hepatology2004,40,41:1
13Four year assessment of ETV resistance in Nucleoside-naive and lamivudine refractory patients显示文摘Colonno R J Rose RE Pokomowski K 2007J Hepatol2007,46,1:1
14Four year assessment of ETV resistance in nucleoside-na ve and lamivudine refractory patients(abstract)显示文摘Colonno R J Rose RE Pokornowskik 2007J Hepatol2007,46,11:1
15Entecavir resistance is rare in nucleoside naive patients with hepatitis B显示文摘Colonno RJ Rose R Baldick CJ 2006Hepatology2006,44,9:1
16Entecavirresistance is rare in nucleoside nave patients with hepatitis B显示文摘COLONNO R J ROSE R BALDICK C J 2006Hepatology2006,44,6:1
17Evidence for the direct involvement of the rhinovims canyon in receptor binding 显示文摘Colonno R J Condra J H Mizutani S 1988Proc Natl Acad Sci1988,85,15:1
18Entecavir (ECV) resistance is not observed in nucleoside-naive subjects and is observed infrequently by week 48 in larnivudine-refractory subjects with chronic HBV infection显示文摘Colonno R Rose RE Levine SM 2005J hepatol2005,42,2:1
19Inhibition of hepatitis B virus polymerase by entecavir显示文摘Langley D R Walsh A W Baldick C J Eggers B J Rose R E Levine S M Kapur A J Colonno R J Ten- ney D J 2007J Virol2007,81,8:1
20Entecavir two year resistance update:no resistance observed in nucleoside native patients and low frequency resistance emergence in lamivudine refractory patients显示文摘Colonno R Rose R Levine S 2005Hepatology2005,42,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费